Announcements Trials
Browse Landscape

Phase

Phase 2 190Phase 1 126Phase 1/2 73Phase NA 39Phase 3 38Phase EARLY_PHASE1 10Phase 2/3 8Phase 4 3

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 118Urinary Bladder Neoplasms 27Carcinoma, Renal Cell 25Kidney Neoplasms 19Neoplasms 14Neoplasm Metastasis 9Breast Neoplasms 9Non-Muscle Invasive Bladder Neoplasms 8Prostatic Hyperplasia 5Pain 5Lung Neoplasms 5Liver Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Melanoma 4Carcinoma, Hepatocellular 4Urologic Neoplasms 3Stomach Neoplasms 3Recurrence 3Prostatic Neoplasms, Castration-Resistant 3Multiple Myeloma 3Kidney Diseases 3Head and Neck Neoplasms 3Carcinoma, Transitional Cell 3Wilms Tumor 2Uterine Cervical Neoplasms 2Tobacco Use Disorder 2Small Cell Lung Carcinoma 2Prostatic Diseases 2Prostate Cancer Metastatic 2Pancreatic Neoplasms 2

Interventions

enfortumab vedotin 1disitamab vedotin 1Vitamin D 1Gemcitabine 1Cholecalciferol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Carcinoma, Transitional Cell × Genitourinary × Clear all
NCT06862219 2026-03-06

A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer

Astellas Pharma Inc

Phase 4 Recruiting
100 enrolled
Genitourinary

Carcinoma, Transitional Cell

NCT05723991 2023-02-13

Study of Disitamab Vedotin Combined With Gemcitabine in Neoadjuvant Treatment of Urothelial Carcinoma

Tongji Hospital

Phase 4 Unknown
36 enrolled
Genitourinary

Carcinoma, Transitional Cell

NCT04197089 2022-08-03

VitDURO

Germans Trias i Pujol Hospital

Phase 4 Completed
2 enrolled
Genitourinary

Carcinoma, Transitional Cell, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡